BRAINSTORM CELL THERAPEUTICS INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $864.0K | $10.8M | $547.0K |
| FY2017 | $5.5M | $11.4M | $2.5M |
| FY2018 | $6.2M | $11.2M | $942.0K |
| FY2019 | $18.8M | $6.5M | $536.0K |
| FY2020 | $15.8M | $51.3M | $37.8M |
| FY2021 | $9.9M | $29.3M | $18.9M |
| FY2022 | $11.5M | $8.5M | $772.0K |
| FY2023 | $9.1M | $4.2M | $1.3M |
| FY2024 | $9.6M | $1.8M | $187.0K |
| FY2025 | $11.0M | $1.0M | $29.0K |